Nanjing Pharmaceutical Company Overview
- Founded
-
1951
- Status
-
Public
- Employees
-
5,062
- Stock Symbol
-
600713
- Investments
-
2
- Share Price
-
$0.78
- (As of Friday Closing)
Nanjing Pharmaceutical Company General Information
Description
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
Contact Information
Primary Industry
Distributors/Wholesale (B2C)
Other Industries
Medical Supplies
Specialty Retail
Stock Exchange
SHG
Primary Office
- Number 486 Zhongshan East Road
- Nanjing, 210002
- China
+850 0000000000
Nanjing Pharmaceutical Company Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.78 | $0.79 | $0.64 - $0.97 | $1.03B | 1.31B | 22.7M | $0.08 |
Nanjing Pharmaceutical Company Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 1,833,912 | 1,779,099 | 1,546,577 | 1,240,147 |
| Revenue | 7,500,292 | 6,988,173 | 5,763,441 | 5,377,377 |
| EBITDA | 203,546 | 233,259 | 169,506 | 165,602 |
| Net Income | 95,975 | 78,237 | 54,485 | 50,208 |
| Total Assets | 4,366,327 | 4,061,077 | 3,617,654 | 3,139,372 |
| Total Debt | 1,013,259 | 1,019,741 | 975,266 | 452,298 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Nanjing Pharmaceutical Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nanjing Pharmaceutical Company Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Yu Liang | President & Director | ||
| Wei Li | Chief Financial Officer | ||
| Xiao Jiang | Chief Operating Officer & Secretary | ||
| Jian Tang | Chief Quality Control Officer |
Nanjing Pharmaceutical Company Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000 0000 | Self | Director | 000 0000 |
| 00000 00000 | Self | Director | 000 0000 |
| 000 0000 | Self | Director | 000 0000 |
| 000 0000 | Self | Chairman | 000 0000 |
| 00 00 | Self | Director | 000 0000 |
Nanjing Pharmaceutical Company Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Nanjing Pharmaceutical Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nanjing Pharmaceutical Company Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 25-Jul-2017 | 000000000 | Pharmaceuticals | ||
| Fujian Southeast Pharmaceutical | Merger/Acquisition | Pharmaceuticals |